Stock Alert: Tyme Technologies Soars 150%

By RTTNews Staff Writer   ✉   | Published:

Shares of Tyme Technologies, Inc. (TYME) soared nearly 150% on Wednesday morning after the company was granted U.S. patent claims covering use of TYME-19.

TYME is currently trading at $4.50, up $2.68 or 147.2527%, on the Nasdaq.

Tyme Technologies announced that it has received notification that the United States Patent and Trademark Office has granted additional patent claims related to the company's metabolomic platform. The patent, U.S. Patent No. 10,905,698, is directed to methods for treating COVID-19.

TYME-19 is an investigational compound that is not approved in the U.S. for any disease indication.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting its financial results for the fourth quarter on Tuesday, Amazon said that Jeff Bezos will step down as Chief Executive Officer of the company and transition to the role of Executive Chair in the third quarter of 2021. Andy Jassy, who currently leads Amazon Web Services or AWS, will succeed Bezos and become only the second CEO of Amazon in the online retail giant's 27-year history. Grocery giant Kroger Co. is planning to close two of its stores in Long Beach, California to avoid a mandatory pay hike of $4 per hour for front-line employees in hazard pay for working during the coronavirus pandemic, multiple reports said. The decision was taken after the Long Beach City Council last month passed a Hazard Pay law requiring some supermarkets to pay the temporary hike. CVS Health Corp. said it will offer COVID-19 vaccinations to eligible people at a limited number of CVS Pharmacy locations across 11 states. It will start with approximately 250,000 total doses, which is sourced directly from the federal government through the pharmacy partnership program. The select pharmacies will start offering COVID-19 vaccinations from February 11.